According to a market report by Lucintel, the future of the global failed back surgery syndrome treatment device market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global failed back surgery syndrome treatment device market is expected to grow with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the increasing prevalence of back pain, the rising demand for non-invasive treatments, and the growing advancements in spinal technologies.
A more
than 150-page report to understand trends, opportunity and forecast in global
failed back surgery syndrome treatment device market to 2031 by type (spinal
cord stimulators and radiofrequency ablation devices), application (hospitals
and ambulatory surgery centers), and region (North America, Europe, Asia
Pacific, and the Rest of the World).
Lucintel
forecasts that, within the type category, spinal cord stimulator is expected to
witness higher growth over the forecast period.
Within the
application category, ambulatory surgery center is expected to witness higher
growth.
Download
sample by clicking on failed
back surgery syndrome treatment device market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Boston
Scientific Corporation, Medtronic, Stryker Corporation, Johnson & Johnson,
Avanos Medical Devices, Abbott Laboratories, Cosman Medical are the major
suppliers in the failed back
surgery syndrome treatment device market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com to get
access of more than 1000 reports at fraction of cost visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment